Results: The mean value of FeNO was 16.14 6 10.04 ppb. The reference value of FeNO, which was defined as the value of 95% in distribution curve, was same or less than 34 ppb. In a univariate analysis, FeNO levels were not associated with age, BMI and smoking history. However, atopy status (18.2 6 11.8 for atopy and 15.1 6 8.5 for nonatopy groups, P ¼ 0.008) and gender (17.8 6 10.2 for male and 14.8 6 9.8 for female groups, P , 0.001) were positively associated with FeNO levels. In stratified analysis, the significance of both variables remained unchanged (P , 0.001). Background: Asthma is a chronic multifactorial disease characterized by inflammation with multiple triggers. Inflamation of the airways is the main pathologic pathway in asthma, and not only determines the diagnosis and severity of symptoms, but is also useful to establish treatment and predict potential complications. By measuring FeNO levels, an indirect level of pulmonary inflammation can be obtained since it is produced by alveolar macrophages in response cytokines. One of the main known causes of this inflammatory response is an allergic reaction. This allergic reaction sets off a cascade of biochemical events that leads to the expression of inflamatory mediators, preformed or de novo, and IgE being the principal of such mediators. The objective was to evaluate the relationship between levels of FeNO and IgE to inflammation and allergy severity. Methods: 50 patients (72% female and 28% male) aged 12 to 50 years old, diagnosed with asthma were taken from the Allergy and Immunology department. A complete medical history was performed, and the diagnosis was confirmed through a clinical history and spirometric criteria, according to GINA 2010. All medications that could alter the inflammatory process were taken away for 15 days. Lastly, total serum IgE levels were measured with electrochemiluminescence technique and the FeNO with standard procedures. The data was further analyzed using a Pearson's correlation test. Results: 21% of the participants showed normal IgE values (,100 UI/Ml) and 33% of the participants had normal FeNO measurements (,20 ppm). A 0.29 coefficient was measured using a Pearson's correlation test, which suggests a low positive correlation between the 2 observed variables.
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Conclusions:
The results showed a low correlation between the IgE and FeNO levels. This result does not allow for a correlation between both parameters; which leads to a conclusion that high levels of IgE from an allergic reaction is not necessarily going to lead to a high FeNO, thus a pulmonary inflammation. Additionally, it emphasizes the importance of the allergists and pneumonologists to work together when treating an asthma patient, given the multidisciplinary nature of this pathology. Background: Asthma is a chronic inflammatory disorder in the airways. Measurement of FeNO (fractional exhaled nitric oxide) is a non-invasive tool for measuring airway inflammation. The aim of this study was to investigate the relationship of FeNO and acute asthmatic exacerbation in children and to decide whether measurement of FeNO could predict acute exacerbation of asthma. Methods: Thirty eight children with mild to moderate persistent asthma aged from 3 to 15 years were included. Patient's data were based on out-patient records. FeNO was measured thorough chemiluminescence analyzer. Prospectively, the patients were followed for 6 month. The FeNO levels of asthma exacerbation group and non-exacerbation groups were evaluated. Results: Mean age of the patients is 5.4 years. There were no difference of peripheral blood total eosinophil count, serum IgE, age, sex between asthma exacerbation group and non-exacerbation group. In the range of abnormal FeNO level (more than 10 ppb), there was significant difference of FeNO level between exacerbation group and non-exacerbation group (P ¼ 0.004). There was also significant correlation between FeNO level and acute asthma exacerbation (P ¼ 0.003). Conclusions: Measurement of FeNO can be a useful tool to predict asthma exacerbation in mild to moderate persistent asthmatic children. Department of Internal Medicine, Sungae General Hospital, Seoul, South Korea. Background: While asthma control is defined as the extent to which the various manifestations of asthma are reduced by treatment, current guidelines of asthma recommend assessment of asthma control without consideration of airway inflammation. Our aim was to investigate the relationships between fractional exhaled nitric oxide (FeNO), a reliable marker of airway inflammation, and levels of asthma controls in patients treated with inhaled corticosteroid (ICS). Methods: We enrolled 71 adult patients with asthma, who had been treated with ICS more than 4 months. Asthma control was assessed by the physician based on the Global Initiative for Asthma guidelines, and by the patients and by using Asthma Control Test (ACT). Statistical analyses were performed to analyze the relationships between FeNO and measures of asthma control and clinical indices for asthma manifestations. Results: There was no significant difference in FeNO levels between 3 groups according to levels of asthma control (controlled, partly controlled and uncontrolled) determined by the physician (P ¼ 0.81) and by the patients (P ¼ 0.81). In addition, FeNO values were not correlated with the ACT scores (r ¼ 0.031, P ¼ 0.807), while FeNO showed peripheral blood eosinophil counts (P , 0.001). Conclusions: These findings demonstrated that FeNO levels are not related with the measures of asthma control in patients treated with ICS. Information of airway inflammation from FeNO concentrations seems to be discrepant from levels of asthma control.
